Rhythm Pharmaceuticals Inc (RYTM)
52.91
-0.81
(-1.51%)
USD |
NASDAQ |
Mar 25, 16:00
53.00
+0.09
(+0.17%)
Pre-Market: 08:25
Rhythm Pharmaceuticals Max Drawdown (5Y): 92.10% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cytokinetics Inc | 61.54% |
| Geron Corp | 86.09% |
| MannKind Corp | 97.67% |
| Altimmune Inc | 99.74% |
| Regeneron Pharmaceuticals Inc | 44.76% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -11.91 |
| Beta (5Y) | 2.300 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 141.8% |
| Historical Sharpe Ratio (5Y) | 0.148 |
| Historical Sortino (5Y) | 0.4734 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.45% |